| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 02/04/2010 | WO2010012964A2 Thiophene-2-carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 02/04/2010 | WO2010012806A2 Substituted indole sulfonamide compounds, their preparation and use as medicaments |
| 02/04/2010 | WO2010012745A2 Benzimidazoles |
| 02/04/2010 | WO2010012620A1 Pyrrolidin-3-ylmethyl-amine as orexin antagonists |
| 02/04/2010 | WO2010012442A2 Insecticidal benzenedicarboxamide derivative |
| 02/04/2010 | WO2010012397A1 N-(indol-3-ylalkyl)(hetero)arylamide derivatives as modulators of the ep2 receptor |
| 02/04/2010 | WO2010012121A1 Aralkyl substituted piperidine or piperazine derivatives and their use for treating schizophrenia |
| 02/04/2010 | WO2010012107A1 Selective glycosidase inhibitors and uses thereof |
| 02/04/2010 | WO2009129267A3 Small molecule inhibitors of the pleckstrin homology domain and methods for using same |
| 02/04/2010 | US20100029730 such as N-acetyl-N-(4'-bromo-1,1'-biphenyl-2-yl)-4-(difluoromethyl)-2-methyl-1,3-thiazole-5-carboxamide, used for controlling unwanted phytopathogenic fungi; microbiocides |
| 02/04/2010 | US20100029722 Organic compounds |
| 02/04/2010 | US20100029718 Organic compounds |
| 02/04/2010 | US20100029696 Indolylamino quinazoline derivatives as antitumor agents |
| 02/04/2010 | US20100029694 Heterocyclic compounds and their use as aldosterone synthase inhibitors |
| 02/04/2010 | US20100029690 Nitrogen-containing heterocyclic compounds |
| 02/04/2010 | US20100029688 Bipiperidinyl compounds, compositions containing such compounds and methods of treatment |
| 02/04/2010 | US20100029685 Oxadiazole and thiadiazole compounds and their use as nicotinic acetylcholine receptor modulators |
| 02/04/2010 | US20100029681 Heterocyclic compounds as calcium channel blockers |
| 02/04/2010 | US20100029664 Pyrrolidin-3-ylmethyl-amine as orexin antagonists |
| 02/04/2010 | US20100029649 Phenyl-substituted pyrimidine compounds useful as kinase inhibitors |
| 02/04/2010 | US20100029641 Aryl sulfamide derivatives and methods of their use |
| 02/04/2010 | US20100029632 improved pharmacokinetics |
| 02/04/2010 | US20100029626 Cyclic sulfones useful as mitochondrial sodium-calcium exchangers |
| 02/04/2010 | US20100029625 Therapeutic Agent for Restenosis |
| 02/04/2010 | US20100029611 Sphingosine-1-phosphate (S1P) receptor modulating agents such as 1-((3-fluoro-4-(5(1-phenylcyclopropyl)thiazolo[5,4-b]pyridin-2-yl)phenyl)methyl)azetidine-3-carboxylic acid, used for the treatment of autoimmune diseases; side effect reduction |
| 02/04/2010 | CA2732631A1 Pyrrolidinyl-alkyl-amide derivatives their preparation and their therapeutic application as ccr3 receptor ligands |
| 02/04/2010 | CA2732618A1 Pyrrole carboxylic acid derivatives as antibacterial agents |
| 02/04/2010 | CA2732336A1 Selective glycosidase inhibitors and uses thereof |
| 02/04/2010 | CA2731873A1 1,2,4-oxadiazole substituted piperidine and piperazine derivatives as smo antagonists |
| 02/04/2010 | CA2731403A1 Pyrrolidin-3-ylmethyl-amine as orexin antagonists |
| 02/04/2010 | CA2731358A1 5/5-or 5/6-membered condensed ring cycloalkylamine derivative |
| 02/04/2010 | CA2731323A1 Cycloalkylidene and heterocycloalkylidene histone deacetylase inhibitor compounds |
| 02/04/2010 | CA2729581A1 Fluorinated heteroaryls |
| 02/03/2010 | EP2149573A1 Substituted indole sulfonamide compounds their preparation and use as medicaments |
| 02/03/2010 | EP2149561A1 Tetrahydroisoquinolin-1-one derivative or salt thereof |
| 02/03/2010 | EP2149551A1 N-(indol-3-ylalkyl)-(hetero)arylamid derivatives as modulators of EP2 receptors |
| 02/03/2010 | EP2149550A1 Nitrogen-containing five-membered heterocyclic compound |
| 02/03/2010 | EP2148879A1 Thia(dia)zoles as fast dissociating dopamine 2 receptor antagonists |
| 02/03/2010 | EP2148878A1 Novel heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 02/03/2010 | EP2148876A1 Pyrazolone derivatives as pde4 inhibitors |
| 02/03/2010 | EP2148868A1 Novel aromatic heterocyclic carboxylic acid amide derivatives useful as potassium channel modulators |
| 02/03/2010 | EP2148677A1 Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases |
| 02/03/2010 | EP1778677B1 Heterocyclic condensed compounds useful as antidiuretic agents |
| 02/03/2010 | CN101638410A Meloxicam compound and purifying method thereof |
| 02/03/2010 | CN101638409A Preparation method of 4-methyl-3-[(2- methyl-4-amido-5- purimidyl) methyl]-5-(2-hydroxide ethide) thiazole onium nitrate |
| 02/03/2010 | CN100586945C Substituted 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazine derivatives and their use as neurokinin antagonists |
| 02/03/2010 | CN100586944C 2,4,5,6-substituted pyrimidines, method for the production and use thereof for preventing epiphyte |
| 02/02/2010 | US7655804 Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient |
| 02/02/2010 | US7655797 Intermediates for making 2,4-pyrimidinediamine compounds |
| 02/02/2010 | US7655688 Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 02/02/2010 | US7655684 1-(Urea-, thiourea- and cyanoguanidine-methylene)benzyl)imidaoles, treatment of neuronal disorders, especially Alzheimer's disease, Down Syndrome, Parkinson's disease and Huntington's disease |
| 02/02/2010 | US7655680 (E)-3-[2-(3,4-diethoxyphenyl)thiazole-4-yl]-1-(2-methoxyphenyl)propenone; inhibiting the activity of phosphodiesterase 4, the production of tumor necrosis factor alpha, and the production of interleukin 4; atopic dermatitis |
| 02/02/2010 | US7655676 Selective activity against propionibacterium acne; minimum inhibitory concentration (MIC) against Propionibacterium acnes strains both sensitive and resistant to erythromycin and clindamycin and against a series Staphylococcus strains |
| 02/02/2010 | US7655663 (2S)-4,4-difluoro-1-(2-{[1-(2-pyrazinyl)piperidin-4-yl]amino}acetyl)-2-pyrrolidine carbonitrile; enzyme inhibitors; diabetes |
| 02/02/2010 | US7655650 Oxadiazine derivatives |
| 02/02/2010 | US7655649 Inhibitors of Akt activity |
| 02/02/2010 | US7655645 Indole derivatives |
| 02/02/2010 | CA2516682C Imidazol-4-yl-ethynyl-pyridine derivatives |
| 02/02/2010 | CA2418868C 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists |
| 02/02/2010 | CA2407428C Hydantoin-containing glucokinase activators |
| 02/02/2010 | CA2333963C Carboxylic acids and carboxylic acid isosteres of n-heterocyclic compounds |
| 02/02/2010 | CA2294809C Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and compositions containing same |
| 01/28/2010 | WO2010011853A2 Beta-and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds |
| 01/28/2010 | WO2010011657A1 Bicyclic heterocycle derivatives as histamine h3 receptor antagonists |
| 01/28/2010 | WO2010011653A1 Tricyclic heterocycle derivatives as histamine h3 antagonists |
| 01/28/2010 | WO2010011375A2 Inhibitors of janus kinases |
| 01/28/2010 | WO2010011316A1 SUBSTITUTED 1,2,3,4- TETRAHYDROCYCLOPENTA[b]INDOL-3-YL) ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS |
| 01/28/2010 | WO2010010970A1 Coloring matter for optical information recording medium and optical information recording medium |
| 01/28/2010 | WO2010010797A1 Pharmaceutical composition comprising dyrk-inhibiting compound |
| 01/28/2010 | WO2010010566A1 Improved process for the manufacture of ziprasidone |
| 01/28/2010 | WO2010010288A2 Alkylthiazol carbamate derivatives, preparation thereof and therapeutic use thereof |
| 01/28/2010 | WO2009140089A3 Sulfone compounds which modulate the cb2 receptor |
| 01/28/2010 | WO2008137816A8 Tricyclic compounds as matrix metalloproteinase inhibitors |
| 01/28/2010 | US20100022773 Apoptosis promoters |
| 01/28/2010 | US20100022772 Process for the synthesis of biaryl oxazolidnones |
| 01/28/2010 | US20100022596 Epothilone analogues |
| 01/28/2010 | US20100022592 Thiazole derivatives as modulators of g protein-coupled receptors |
| 01/28/2010 | US20100022550 Tetrahydrocarbazole derivatives useful as androgen receptor modulators |
| 01/28/2010 | US20100022544 Cyclically substituted 3,5-dicyano-2-thiopyridines and use thereof |
| 01/28/2010 | US20100022543 Cycloalkylidene and heterocycloalkylidene inhibitor compounds |
| 01/28/2010 | US20100022542 Compounds exhibiting thrombopoietin receptor agonism |
| 01/28/2010 | US20100022537 I-pheny 1-3,4-dihydropyrimidin-2(1h)-one derivatives and their use |
| 01/28/2010 | US20100022522 HETEROARYL SUBSTITUTED PYRROLO[2,3-b]PYRIDINES AND PYRROLO[2,3-b]PYRIMIDINES AS JANUS KINASE INHIBITORS |
| 01/28/2010 | US20100022521 Compounds |
| 01/28/2010 | US20100022516 4,5-Disubstituted-2-aryl pyrimidines |
| 01/28/2010 | US20100022510 Crystalline Forms |
| 01/28/2010 | US20100022506 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors |
| 01/28/2010 | US20100021385 Benzoxazole derivatives |
| 01/28/2010 | CA2731869A1 Beta-and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds |
| 01/28/2010 | CA2731789A1 Alkyl thiazole carbamate derivatives, preparation thereof, and use thereof as faah enzyme inhibitors |
| 01/28/2010 | CA2730500A1 Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid deri vatives useful in the treatment of autoimmune and inflammatory disorders |
| 01/28/2010 | CA2719847A1 Inhibitors of janus kinases |
| 01/27/2010 | EP2147914A1 Aminodihydrothiazine derivatives substituted with cyclic groups |
| 01/27/2010 | EP2146964A2 Ethers of naphtalene carboxylic acid amides as cancer cure |
| 01/27/2010 | EP2146779A1 Sulfonyl amide derivatives for the treatment of abnormal cell growth |
| 01/27/2010 | EP2146718A1 Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases |
| 01/27/2010 | EP2146717A1 Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases |
| 01/27/2010 | EP2146716A1 Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases |
| 01/27/2010 | EP2146715A1 Cgrp receptor antagonists with tertiary amide, sulfonamide, carbamate and urea end groups |
| 01/27/2010 | EP1919903B1 Bicyclic bisamide derivatives and use thereof as insecticides |